Feng Hsiung
CIK: 0002059159
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SNTI
Senti Biosciences, Inc.
Director
Discretionary Trading P&L
Holdings
About Hsiung Feng
Hsiung Feng (SEC CIK 0002059159) files insider reports with the SEC as Director of Senti Biosciences, Inc. (SNTI).
Signal8 holds 3 ownership filings by Hsiung Feng (1 Form 3, 2 Form 4), filed between Mar 11, 2025 and Jun 27, 2025. Those filings report 2 transactions, from Mar 7, 2025 to Jun 25, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Hsiung Feng's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Hsiung Feng
Other insiders filing for Senti Biosciences, Inc. (SNTI)
- Rajangam Kanya, Pres. & Chief Med. & Dev. Off.
- Lu Timothy K, CEO
- Baum Bryan Daniel, Director
- Collins James J., Director
- Schulz Fran, Director
- COOPERSTONE BRENDA, Director